GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » GF Value

Tecogen (Tecogen) GF Value : $1.37 (As of May. 12, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tecogen GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-12), Tecogen's share price is $0.685. Tecogen's GF Value is $1.37. Therefore, Tecogen's Price-to-GF-Value for today is 0.50.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Tecogen is Possible Value Trap, Think Twice.


Tecogen  (OTCPK:TGEN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Tecogen's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.685/1.37
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tecogen GF Value Related Terms

Thank you for viewing the detailed overview of Tecogen's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Tecogen (Tecogen) Business Description

Traded in Other Exchanges
Address
45 First Avenue, Waltham, MA, USA, 02451
Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production. Products segment designs, manufactures and sells industrial and commercial cogeneration systems. Services segment provides operations and maintenance services and turn-key installation for products under long term service contracts. Energy Production segment sells energy in the form of electricity, heat, hot water and cooling to the customers under long-term energy sales agreements.
Executives
Earl R Lewis director C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos director, 10 percent owner, officer: Chief Executive Officer 85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch director 280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh director, officer: Chief Financial Officer 45 FIRST AVE, WALTHAM MA 02451
John M Albertine director 100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown 10 percent owner, other: Trustee C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins director 45 FIRST AVE, WALTHAM MA 02451
Fred Holubow director
Locke M. Benjamin officer: Co-CEO 45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv officer: General Counsel & Secretary 49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen director 45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas 10 percent owner TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell director 6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson director C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison officer: CFO, Treasurer and Secretary C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420